1. Home
  2. MNPR
  3. MNPR News

Latest Monopar Therapeutics Inc. (MNPR) News on August 17, 2025

MNPR

MT Newswires

a month ago

Monopar Therapeutics Insider Sold Shares Worth $672,020, According to a Recent SEC Filing

Chardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives Buy
MNPR

Insider Monkey

2 months ago

Chardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives Buy

Institutional investors own a significant stake of 29% in Monopar Therapeutics Inc. (NASDAQ:MNPR)
MNPR

Simply Wall St.

2 months ago

Institutional investors own a significant stake of 29% in Monopar Therapeutics Inc. (NASDAQ:MNPR)

MNPR

MT Newswires

2 months ago

Chardan Initiates Monopar Therapeutics at Buy With $60 Price Target

Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know
MNPR

Zacks

2 months ago

Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
MNPR

GlobeNewswire

2 months ago

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls
MNPR

TipRanks

2 months ago

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls

MNPR

MT Newswires

2 months ago

Monopar Therapeutics to Join Russell Indexes

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
MNPR

GlobeNewswire

2 months ago

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments
MNPR

GlobeNewswire

3 months ago

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025
MNPR

GlobeNewswire

3 months ago

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025
MNPR

Insider Monkey

4 months ago

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
MNPR

GlobeNewswire

4 months ago

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

MNPR

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 04/07/2025

We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth
MNPR

Simply Wall St.

4 months ago

We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth

Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
MNPR

GlobeNewswire

5 months ago

Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments

Why Monopar Therapeutics Inc (MNPR) Is Skyrocketing So Far In 2025
MNPR

Insider Monkey

6 months ago

Why Monopar Therapeutics Inc (MNPR) Is Skyrocketing So Far In 2025

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
MNPR

PR Newswire

7 months ago

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
MNPR

TipRanks

7 months ago

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright

MNPR

MT Newswires

7 months ago

Piper Sandler Initiates Monopar Therapeutics at Overweight With $72 Price Target

MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN
MNPR

Zacks

7 months ago

MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN

These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
MNPR

TipRanks

8 months ago

These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024
MNPR

Zacks

8 months ago

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

MNPR

MT Newswires

8 months ago

Monopar Therapeutics Prices $40 Million Offering, Private Placement

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
MNPR

GlobeNewswire

8 months ago

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

MNPR

MT Newswires

8 months ago

Monopar Therapeutics Shares Jump After First Patient Dosed in Cancer Therapy

Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
MNPR

GlobeNewswire

8 months ago

Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu

Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
MNPR

GlobeNewswire

8 months ago

Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference

Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
MNPR

GlobeNewswire

9 months ago

Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

MNPR

MT Newswires

10 months ago

Monopar Therapeutics Closes $19.2 Million Common Stock Offering

Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
MNPR

GlobeNewswire

10 months ago

Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock

MNPR

MT Newswires

10 months ago

Monopar Therapeutics Prices Best Efforts Public Offering at $16.25 per Share

Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
MNPR

GlobeNewswire

10 months ago

Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock

Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
MNPR

GlobeNewswire

10 months ago

Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock

Individual investors are Monopar Therapeutics Inc.'s (NASDAQ:MNPR) biggest owners and were rewarded after market cap rose by US$40m last week
MNPR

Simply Wall St.

10 months ago

Individual investors are Monopar Therapeutics Inc.'s (NASDAQ:MNPR) biggest owners and were rewarded after market cap rose by US$40m last week

Monopar Therapeutics Secures License for Wilson Disease Treatment
MNPR

TipRanks

10 months ago

Monopar Therapeutics Secures License for Wilson Disease Treatment

MNPR

MT Newswires

10 months ago

Top Midday Gainers

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
MNPR

GlobeNewswire

10 months ago

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
MNPR

GlobeNewswire

10 months ago

Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024

Monopar Therapeutics Expands Portfolio with New Patent Filing
MNPR

TipRanks

10 months ago

Monopar Therapeutics Expands Portfolio with New Patent Filing

Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
MNPR

GlobeNewswire

10 months ago

Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers

Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial
MNPR

TipRanks

10 months ago

Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial

Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
MNPR

GlobeNewswire

10 months ago

Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers

MNPR

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise in Thursday Trading

MNPR

MT Newswires

a year ago

Top Midday Gainers

MNPR

MT Newswires

a year ago

Monopar Therapeutics Says Early Data Validate Potential Cancer Treatment; Shares Jump

Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
MNPR

GlobeNewswire

a year ago

Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr

Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
MNPR

GlobeNewswire

a year ago

Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
MNPR

GlobeNewswire

a year ago

Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule

MNPR

MT Newswires

a year ago

Monopar Receives Clearance in Australia for Phase 1 Trial of Radiopharmaceutical in Advanced Cancers

Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
MNPR

GlobeNewswire

a year ago

Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers

Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
MNPR

GlobeNewswire

a year ago

Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr

Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation
MNPR

Simply Wall St.

a year ago

Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation

Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested
MNPR

TipRanks

a year ago

Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested

Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
MNPR

GlobeNewswire

a year ago

Monopar Therapeutics Announces 1-for-5 Reverse Stock Split

Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
MNPR

GlobeNewswire

a year ago

Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments

Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr
MNPR

GlobeNewswire

a year ago

Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr

Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
MNPR

GlobeNewswire

a year ago

Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24

Monopar and NorthStar Amend & Extend Collaboration
MNPR

GlobeNewswire

a year ago

Monopar and NorthStar Amend & Extend Collaboration

Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
MNPR

GlobeNewswire

a year ago

Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting

MNPR

MT Newswires

a year ago

Monopar Therapeutics Names Karthik Radhakrishnan as CFO

Monopar Announces CFO Succession
MNPR

GlobeNewswire

a year ago

Monopar Announces CFO Succession

Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now
MNPR

Zacks

a year ago

Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now

Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
MNPR

GlobeNewswire

a year ago

Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
MNPR

GlobeNewswire

a year ago

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
MNPR

GlobeNewswire

a year ago

Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
MNPR

GlobeNewswire

a year ago

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MNPR

Zacks

a year ago

Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy
MNPR

Zacks

a year ago

All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
MNPR

GlobeNewswire

a year ago

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments

Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
MNPR

GlobeNewswire

a year ago

Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
MNPR

GlobeNewswire

a year ago

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation
MNPR

Simply Wall St.

a year ago

Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
MNPR

GlobeNewswire

a year ago

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
MNPR

GlobeNewswire

a year ago

Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024
MNPR

GlobeNewswire

2 years ago

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
MNPR

GlobeNewswire

2 years ago

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

OSS and FLYHT Expand Relationship with the Design and Manufacturing of 5G Enabled AFIRS(TM) Edge Solution
MNPR

ACCESSWIRE

2 years ago

OSS and FLYHT Expand Relationship with the Design and Manufacturing of 5G Enabled AFIRS(TM) Edge Solution

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
MNPR

Business Wire

2 years ago

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results

Banzai Executes LOI to Acquire Cliently, An AI-Driven Sales Engagement Platform
MNPR

GlobeNewswire

2 years ago

Banzai Executes LOI to Acquire Cliently, An AI-Driven Sales Engagement Platform

Alarum Technologies Ltd. Featured in Syndicated Broadcast Covering Preliminary Q4 2023 Results Pointing Towards All Time High Operating Cashflow and Revenue
MNPR

GlobeNewswire

2 years ago

Alarum Technologies Ltd. Featured in Syndicated Broadcast Covering Preliminary Q4 2023 Results Pointing Towards All Time High Operating Cashflow and Revenue

ReWalk Robotics Expands Direct Sales Coverage to Canada
MNPR

GlobeNewswire

2 years ago

ReWalk Robotics Expands Direct Sales Coverage to Canada

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
MNPR

GlobeNewswire

2 years ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to February 10, 2024
MNPR

GlobeNewswire

2 years ago

Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to February 10, 2024

United-Guardian Appoints New Director
MNPR

GlobeNewswire

2 years ago

United-Guardian Appoints New Director

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Secures Two Year Time Charter Contract With Oil Major at US$37,200 Per Day

Sunrise New Energy Secures Highly Regarded Japanese Patent for Invention of Lithium-Ion Battery Anode Material Preparation Method
MNPR

GlobeNewswire

2 years ago

Sunrise New Energy Secures Highly Regarded Japanese Patent for Invention of Lithium-Ion Battery Anode Material Preparation Method

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Signs Shipbuilding Contracts for the Construction of 2 Newbuilding LNG-Ready Scrubber Fitted Tier III LR2 Tankers

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
MNPR

Business Wire

2 years ago

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Announces Full Prepayment of Piraeus Bank S.A. Loans and Significant Reduction of Finance Costs

Metalpha Announces Official Uplift of Type 4 License
MNPR

PR Newswire

2 years ago

Metalpha Announces Official Uplift of Type 4 License

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts
MNPR

CNW Group

2 years ago

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Announces Completion of Sale and Delivery of 2007 Built M/T P. Kikuma to New Owners

CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
MNPR

GlobeNewswire

2 years ago

CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone

MNPR

News Direct

2 years ago

ProSomnus CEO Len Liptak unveils game-changing device and promising clinical trial results for 2024

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Issues 2022 Sustainability Report

Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel
MNPR

GlobeNewswire

2 years ago

Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel

Uzma and Satellogic Sign Multi-Million Dollar +3-Year Agreement to Advance Geospatial Capabilities in Southeast Asia
MNPR

Business Wire

2 years ago

Uzma and Satellogic Sign Multi-Million Dollar +3-Year Agreement to Advance Geospatial Capabilities in Southeast Asia

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2023

MNPR

GlobeNewswire

2 years ago

Performance Shipping Inc. Announces Filing of Amendment No. 2 to the Solicitation and Recommendation Statement on Schedule 14D-9

Share on Social Networks: